Free Newsletter
Blood vessel cells aid in adult stem cell growth
Researchers at Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the building blocks of blood vessels, produce growth factors that can grow large amounts of adult stem cells. This discovery could help scientists find a way to manufacture an endless supply of blood related stem cells. And with an unlimited supply, patients who need bone marrow transplants could get them irrespective of whether they're able to find a genetic match.
"This study will have a major impact on the treatment of any blood-related disorder that requires a stem cell transplant," says the study's senior author, Dr. Shahin Rafii. "Most stem cells, even in the presence of multiple growth factors, serum, and support from generic non-endothelial stromal cells, die after a few days. Now, employing our endothelial stem cell co-cultures, we can propagate bona fide adult stem cells in the absence of external factors and serum beyond 21 days with an expansion index of more than 400-fold," he explains.
"This is groundbreaking research with potential application for regeneration of organs and inhibition of cancer cell growth," adds Dr. Antonio Gotto Jr., provost for medical affairs of Cornell University.
The vascular-cell model established in this study could also be used to grow abundant functional stem cells from other organs such as the brain, heart, skin and lungs. An article detailing these findings appears in the March 5 issue of the journal Cell Stem Cell.
- see the Cornell press release
- check out the study abstract
- see this story for more
Related Articles:
New method spurs proliferation of adult stem cells
Pfizer expands adult stem cell therapy work
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: